Investor.lilly.com

Tirzepatide reduced sleep apnea severity by up to nearly …

WebThe overall safety profile of tirzepatide in SURMOUNT-OSA studies was similar to previously reported SURMOUNT and SURPASS trials. The most commonly …

Actived: Just Now

URL: https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-sleep-apnea-severity-nearly-two-thirds

Lilly Launches End-to-End Digital Healthcare Experience …

WebINDIANAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced LillyDirect™, a new digital healthcare experience for patients in the U.S. …

Category: Health Go Health

Lilly Reports First-Quarter 2024 Financial Results and …

WebMounjaro For Q1 2024, worldwide Mounjaro revenue was $1.81 billion compared with $568.5 million in Q1 2023. U.S. revenue was $1.52 billion compared with …

Category: Health Go Health

Zepbound™ (tirzepatide) is Now Available in U.S.

WebExpress Scripts to add Zepbound to National Preferred Formulary. INDIANAPOLIS, Dec. 5, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today …

Category: Health Go Health

FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic …

WebAdults taking Zepbound in a clinical trial lost on average 48 lb. at the highest dose. Zepbound is the first and only approved treatment activating two incretin hormone …

Category: Health Go Health

FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) …

WebOLUMIANT is the first and only JAK inhibitor FDA-approved for the treatment of COVID-19 in certain hospitalized adults requiring various degrees of oxygen …

Category: Health Go Health

FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First …

WebOmvoh achieved primary and key secondary endpoints, including sustained clinical remission in pivotal trials. Omvoh delivered significant improvement in bowel …

Category: Health Go Health

Lilly collaborates internationally with leading diabetes technology

WebINDIANAPOLIS, May 6, 2021 /PRNewswire/ -- With a goal of integrating data and technology to help streamline diabetes management, Eli Lilly and Company (NYSE: LLY) …

Category: Health Go Health

Lilly Highlights Innovation-based Growth Strategy and Pipeline

WebRevenue for 2021 is now expected to be in the range of $28.0 billion to $28.3 billion, reflecting additional revenue from COVID-19 antibodies associated with the …

Category: Health Go Health

Open Letter Regarding the Use of Mounjaro® (tirzepatide) and …

WebOpen Letter Regarding Use of Lilly’s FDA-Approved Tirzepatide Medicines (First published on January 4) Lilly is committed to meeting the needs of people affected …

Category: Medicine Go Health

Lilly to Commit $5 Million to Direct Relief's Fund for Health Equity

WebINDIANAPOLIS, May 3, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its support of Direct Relief's Fund for Health Equity (the Fund) with a $5 …

Category: Health Go Health

Lilly Launches Digital Health Open Innovation Challenge to Help

WebINDIANAPOLIS, Sept. 15, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has launched an open innovation challenge for individuals and teams across the United …

Category: Health Go Health

Results from Lilly's Landmark Phase 3 Trial of Donanemab …

WebFor full TRAILBLAZER-ALZ 2 results, see the publication in JAMA.. A live webcast of the scientific session at AAIC featuring the donanemab presentations can be …

Category: Health Go Health

Lilly's Lower-Priced Insulin Now Available Eli Lilly and Company

WebPeople with additional questions can also contact the Lilly Diabetes Solution Center at (833) 808-1234 from 9 am to 8 pm EST Monday through Friday to speak with a …

Category: Health Go Health

Lilly Announces Agreement to Acquire Novartis Animal Health

WebINDIANAPOLIS, April 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 …

Category: Health Go Health